PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 323.50
Bid: 325.00
Ask: 328.50
Change: -7.50 (-2.27%)
Spread: 3.50 (1.077%)
Open: 329.00
High: 332.00
Low: 320.00
Prev. Close: 331.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Fri, 16th Apr 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES EXPERIAN TO 'BUY' ('NEUTRAL') - TARGET 3,250 (3,000) PENCE

----------

UBS RAISES MONDI PRICE TARGET TO 2,160 (2,070) PENCE - 'BUY'

----------

JPMORGAN RAISES BT GROUP PRICE TARGET TO 230 (175) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ENTAIN PRICE TARGET TO 1,872 (1,647) PENCE - 'BUY'

----------

BERENBERG RAISES HALMA PRICE TARGET TO 2,385 (2,310) PENCE - 'HOLD'

----------

JPMORGAN RAISES BT GROUP PRICE TARGET TO 230 (175) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES BP TO 'BUY' ('HOLD') - PRICE TARGET 355 PENCE

----------

CREDIT SUISSE RAISES TESCO PRICE TARGET TO 283 (280) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

RBC CUTS DIXONS CARPHONE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 150 PENCE

----------

RBC RAISES WH SMITH TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 2,200 (2,100) PENCE

----------

MORGAN STANLEY RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 260 (240) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,300 (1,280) PENCE - 'BUY'

----------

JPMORGAN RAISES MAN GROUP PRICE TARGET TO 185 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 1,949 (1,900) PENCE - 'BUY'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 1,949 (1,900) PENCE - 'BUY'

----------

PEEL HUNT CUTS SPECTRIS TO 'ADD' ('BUY')

----------

BERENBERG RAISES SPECTRIS PRICE TARGET TO 3,640 (3,505) PENCE - 'BUY'

----------

BERENBERG RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,465 (2,300) PENCE - 'BUY'

----------

RBC RAISES BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 400 (385) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 405 (415) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

CREDIT SUISSE RAISES ROBERT WALTERS PRICE TARGET TO 650 (530) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES THG PRICE TARGET TO 1,000 (885) PENCE - 'BUY'

----------

BERENBERG INITIATES BEGBIES TRAYNOR WITH 'BUY' - TARGET 155 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more
30 Oct 2020 08:47

Oxford Biomedica partner delays Parkinson's disease treatment trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.

Read more
23 Oct 2020 15:15

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

Read more
6 Oct 2020 14:19

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Read more
6 Oct 2020 09:44

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Read more
6 Oct 2020 07:55

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

Read more
6 Oct 2020 07:43

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

Read more
6 Oct 2020 07:03

Oxford Biomedica new manufacturing suite approved

(Sharecast News) - Oxford Biomedica said it had received government approval for a fourth manufacturing suite within its Oxbox facility which will be used to develop a potential Covid-19 vaccine.

Read more
17 Sep 2020 10:43

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Read more
17 Sep 2020 08:35

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

Read more
17 Sep 2020 07:52

LONDON MARKET PRE-OPEN: Next Raises Full-Year Profit Outlook

LONDON MARKET PRE-OPEN: Next Raises Full-Year Profit Outlook

Read more
17 Sep 2020 07:01

Oxford Biomedica sees swing to FY profit on Covid vaccine hopes

(Sharecast News) - Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.